This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Vizgen files reply in support of blocking patent injunction request filed by 10x Genomics, Harvard

( November 20, 2023, 21:53 GMT | Official Statement) -- MLex Summary: Vizgen filed a reply in support of enjoining 10x Genomics and Harvard College from seeking an injunction via patent infringement proceedings initiated against Vizgen in the Unified Patent Court of Europe. “The UPC action is not an unrelated parallel proceeding. It is part of plaintiffs’ larger unlawful scheme from which Vizgen seeks relief in this court. There is no dispute that plaintiffs’ European patents are […] patents subject to the same licensing promises plaintiffs made to the US government.  The European patents are the counterparts to the patents asserted before this court, and the UPC action reflects plaintiffs’ unlawful ‘closing the door’ on Vizgen,” it argued.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections